Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases

Neurology

Volumn 50, Issue 4, 1998, Pages 1033-1040

  Hoang, T Q ^a   Bluml, S ^b   Dubowitz, D J ^a   Moats, R ^a   Kopyov, O ^c   Jacques, D ^c   Ross, B D ^a,d  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b Rudi Schulte Research Institute   (United States)

^c GOOD SAMARITAN HOSPITAL   (United States)

^d HMRI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; NUCLEAR MAGNETIC RESONANCE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE DIAGNOSIS; WHITE MATTER;

EID: 0031900412     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.1033     Document Type: Article

References (27)

1. Weatherall DG, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine, 2nd ed. Oxford: Oxford University Press, 1987.
2. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38:379-387.
3. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994;35:172-180.
4. Spencer D, Robbins R, Naftolin F, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992;327:1541-1548.
5. Peschanski M, Defer G, Nguyen JP, et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994;117:487-499.
6. Madrazo I, Franco-Bourland RE, Castrejon H, et al. Fetal striatal homotransplantation for Huntington's disease: first two case reports. Neurol Res 1995;17:312-315.
7. Beal MF. Neurochemistry and toxin models in Huntington's disease. Curr Opin Neurol 1994;7:542-547.
8. 1H NMR spectroscopy. Neurology 1993; 43:2689-2695.
9. Davie CA, Barker GJ, Quinn N, Tofts PS, Miller DH. Proton MRS in Huntington's disease. Lancet 1994;343:1580.
10. 1H MRS in the evaluation of preoperative patients with Huntington's disease. Proc Soc Mag Res Med 1997;1:293.
11. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. Part II. Metabolite concentrations. J Magn Reson 1993;102:9-19.
12. Tan J, Blüml S, Hoang T, Dubovitz D, Merenhamp G, Ross B. Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Res Med 1998 (in press).
13. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116.
14. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. Part I. Compartments and water. J Magn Reson 1993;102:1-8.
15. Ye FQ, Wayne WR, Allen PS. Estimation of brain iron in vivo by means of the interecho time dependence of image contrast. Magn Reson Med 1996;36:153-158.
16. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
17. Lentner C, ed. Geigy scientific tables, 8th ed. Basel: Ciba-Geigy, 1981.
18. Miller AL, Hawkins RA, Veech RL. Phenylketonuria: phenylalanine inhibits brain pyruvate kinase in vivo. Science 1973; 179:904-905.
19. Hedreen JC, Folstein SE. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995;54:105-120.
20. Peyser CE, Folstein M, Chase GA, et al. Trial of d-α tocopherol in Huntington's disease. Am J Psychiatry 1995;152:1771-1775.
21. Taylor-Robinson SD, Weeks RA, Sargentoni, et al. Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy. Lancet 1994;343:1170.
22. Pearson SJ, Reynolds GP. Neocortical neurotransmitter markers in Huntington's disease. J Neural Transm (Gen Sect) 1994;98:197-207.
23. Holshouser BA, Komu M, Möller HE, et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn Res Med 1995;33:589-594.
24. Block RE, Brown BC, Sanchez-Ramos J, Lampman DA, Murdoch J. Proton MR spectroscopy of the brain in vivo in Parkinson's disease patients including frequency dependent data corrections. Magn Res Med 1993;1:1548.
25. Bowen BC, Block RE, Sanchez-Ramos J, et al. Proton MR spectroscopy of the brain in 14 patients with Parkinson's disease. Am J Neuroradiol 1995;16:61-68.
26. Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995;37:204-210.
27. Lemmens GM, Chaudhuri K, Ellis C, Williams SCR, Simmons A, Leigh PN. Striatal changes in idiopathic Parkinson's disease: a study using proton magnetic resonance spectroscopy. Magn Res Med 1995;1:389.